1 |
Kharasch, E. D., Schroeder, J. L., Bammler, T., Beyer, R. and Srinouanprachanh, S. (2006) Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difl uoro- 1-(trifluoromethyl)vinyl ether ("compound A") in rats. Toxicol. Sci. 90, 419-431.
|
2 |
Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., Karmpaliotis, D., Burger, A. J., Murphy, S. A., Cannon, C. P., Braunwald, E. and Gibson, C. M; TIMI Study Group. (2005) Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J. Am. Coll. Cardiol. 45, 1781-1786.
DOI
|
3 |
Kohli, H. S., Bhaskaran, M. C., Muthukumar, T., Thennarasu, K., Sud, K., Jha, V., Gupta, K. L. and Sakhuja. V. (2000) Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol. Dial. Transplant. 15, 212-217.
DOI
|
4 |
Manor, S. M., Guillory, G. S. and Jain, S. P. (2004) Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting. Pharmacotherapy 24, 664-667.
DOI
|
5 |
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S. and D'Agati, V. D. (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 64, 281-289.
DOI
|
6 |
Markowitz, G. S. and Perazella MA. (2005) Drug-induced renal failure: a focus on tubulointerstitial disease. Clin. Chim. Acta 351, 31-47.
DOI
|
7 |
Mogensen, C. E. (1971) Urinary albumin excretion in early and longterm juvenile diabetes. Scand. J. Clin. Lab. Invest. 28, 101-109.
DOI
|
8 |
Nagai, J. and Takano, M. (2010) Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs. Expert Opin. Drug Metab. Toxicol. 6, 1125-1138.
DOI
|
9 |
Ferguson, M. A., Vaidya, V. S. and Bonventre, J. V. (2008) Biomarkers of nephrotoxic acute kidney injury. Toxicology 245, 182-193.
DOI
|
10 |
Finn, W. and Porter, G. (2003) Urinary biomarkers and nephrotoxicity. Clinical Nephrotoxins (2nd ed), pp. 621-655. Kluwer Academic Publishers, Massachusetts.
|
11 |
Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C. G., Blot, W. J., McLaughlin, J. K., Zack, M. M. and Nyren, O. (2001) Acetaminophen, aspirin, and chronic renal failure. N. Engl. J. Med. 345, 1801-1808.
DOI
|
12 |
Galley, H. F. (2000) Can acute renal failure be prevented? J. R. Coll. Surg. Edinb. 45, 44-50.
|
13 |
Guder, W.G. and Hoffmann, W. (1992) Markers for the diagnosis and monitoring of renal tubular lesions. Clin. Nephrol. 38(Suppl 1), s3-7.
|
14 |
Herget-Rosenthal, S., Poppen, D., Husing, J., Marggraf, G., Pietruck, F., Jakob, H. G., Philipp, T. and Kribben, A. (2004) Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin. Chem. 50, 552-558.
DOI
|
15 |
Horii, Y., Iwano, M., Hirata, E., Shiiki, M., Fujii, Y., Dohi, K. and Ishikawa, H. (1993) Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int. 39(Suppl), S71-75.
|
16 |
Huerta-Alardín, A. L., Varon, J. and Marik, P. E. (2005) Bench-tobedside review: Rhabdomyolysis -- an overview for clinicians. Crit. Care 9, 158-169.
DOI
ScienceOn
|
17 |
Bailly, V., Zhang, Z., Meier, W., Cate, R., Sanicola, M. and Bonventre, J. V. (2002) Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 277, 39739-39748.
DOI
|
18 |
Ichimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L. and Sanicola, M. (1998) Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273, 4135-4142.
DOI
|
19 |
Isnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M. and Vanherweghem, J. L. (2004) Herbs and the kidney. Am. J. Kidney Dis. 44, 1-11.
|
20 |
Alchi, B., Nishi, S., Kondo, D., Kaneko, Y., Matsuki, A., Imai, N., Ueno M., Iguchi, S., Sakatsume, M., Narita, I., Yamamoto, T. and Gejyo, F. (2005) Osteopontin expression in acute renal allograft rejection. Kidney Int. 67, 886-896.
DOI
|
21 |
Baron, S., Tyring, S. K., Fleischmann, W. R. Jr., Coppenhaver, D. H., Niesel, D. W., Klimpel, G. R., Stanton, G. J. and Hughes, T. K. (1991) The interferons. Mechanisms of action and clinical applications. JAMA 266, 1375-1383.
DOI
|
22 |
Bernard, A. M., Vyskocil, A. A., Mahieu, P. and Lauwerys, R. R. (1987) Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin. Chem. 33, 775-779.
|
23 |
Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P. and Dieterle, F. (2010) Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol. 28, 436-440.
DOI
|
24 |
Borregaard, N., Sehested, M., Nielsen, B. S., Sengeløv, H. and Kjeldsen, L. (1995) Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 85, 812-817.
|
25 |
Coco, T. J. and Klasner, A. E. (2004) Drug-induced rhabdomyolysis. Curr. Opin. Pediatr. 16, 206-210.
DOI
|
26 |
Wu, Y., Yang, L., Su, T., Wang, C., Liu, G. and Li, X. M. (2010) Pathological signifi cance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis. Clin. J. Am. Soc. Nephrol. 5, 1954-1959.
DOI
|
27 |
Conti, M., Moutereau, S., Zater, M., Lallali, K., Durrbach, A., Manivet, P., Eschwège, P. and Loric, S. (2006) Urinary cystatin C as a specific marker of tubular dysfunction. Clin. Chem. Lab. Med. 44, 288-291.
|
28 |
Donovan, K. L., Coles, G. A. and Williams, J. D. (1994) An ELISA for the detection of type IV collagen in human urine--application to patients with glomerulonephritis. Kidney Int. 46, 1431-1437.
DOI
|
29 |
Emeigh Hart, S. G. (2005) Assessment of renal injury in vivo. J. Pharmacol. Toxicol. Methods 52, 30-45.
DOI
|
30 |
Wada, T., Yokoyama, H., Tomosugi, N., Hisada, Y., Ohta, S., Naito, T., Kobayashi, K., Mukaida, N. and Matsushima, K. (1994) Detection of urinary interleukin-8 in glomerular diseases. Kidney Int. 46, 455-460.
DOI
|
31 |
Shao, C., Li, M., Li, X., Wei, L., Zhu, L., Yang, F., Jia, L., Mu, Y., Wang, J., Guo, Z., Zhang, D., Yin, J., Wang, Z., Sun, W., Zhang, Z. and Gao, Y. (2011) A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol. Cell Proteomics 10, M111.010975.
|
32 |
Xu, S. Y., Pauksen, K. and Venge, P. (1995) Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand. J. Clin. Lab. Invest. 55, 125-131.
DOI
|
33 |
Zager, R. A. (1997) Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin. Nephrol. 17, 3-14.
|
34 |
Schnellmann, R.G. and Kelly, K.J. (1999). Pathophysiology of nephrotoxic acute renal failure, in atlas of diseases of the kidney vol 1. (R. W. Schrier, Ed.), pp 15.1-15.14. Blackwell Science (Wash DC) Ltd., Oxford.
|
35 |
Schoolwerth, A. C., Sica, D. A., Ballermann, B. J. and Wilcox, C. S; Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. (2001) Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 104, 1985-1991.
DOI
|
36 |
Schurek, H. J., Neumann, K. H., Flohr, H., Zeh, M.and Stolte, H. (2000) Diagnostic and prognostic signifi cance of proteinuria selectivity index in glomerular diseases. Clin. Chim. Acta 297, 73-83.
DOI
|
37 |
Shiraga, H., Min, W., Van Dusen, W.J., Clayman, M.D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., Neilson, E. G. and Hoyer, J. R. (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acidrich protein superfamily. Proc. Natl. Acad. Sci. USA 89, 426-430.
DOI
ScienceOn
|
38 |
Vaidya, V. S., Ferguson, M. A. and Bonventre, J. V. (2008) Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48, 463-493.
DOI
|
39 |
Vaidya, V. S., Ramirez, V., Ichimura, T., Bobadilla, N. A. and Bonventre, J. V. (2006) Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal. Physiol. 290, F517-529.
DOI
|
40 |
Perazella, M. A. (1999) Crystal-induced acute renal failure. Am. J. Med. 106, 459-465.
DOI
|
41 |
Prinsen, B. H., de Sain-van der Velden, M. G., Kaysen, G. A., Straver, H. W., van Rijn, H. J., Stellaard, F., Berger, R. and Rabelink, T. J. (2001) Transferrin synthesis is increased in nephrotic patients insuffi ciently to replace urinary losses. J. Am. Soc. Nephrol. 12, 1017-1025.
|
42 |
Perazella, M. A. (2005) Drug-induced nephropathy: an update. Expert Opin. Drug Saf. 4, 689-706.
DOI
|
43 |
Perneger, T. V., Whelton, P. K. and Klag, M. J. (1994) Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinfl ammatory drugs. N. Engl. J. Med. 331, 1675-1679.
DOI
|
44 |
Pisoni, R., Ruggenenti, P. and Remuzzi, G. (2001) Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf. 24, 491-501.
DOI
|
45 |
Rached E., Hoffmann, D., Blumbach, K., Weber, K., Dekant, W. and Mally, A. (2008) Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin A in vivo and in vitro. Toxicol. Sci. 103, 371-381.
DOI
|
46 |
Rodriguez-Iturbe, B. and Garcia Garcia, G. (2010) The role of tubulointerstitial infl ammation in the progression of chronic renal failure. Nephron. Clin. Pract. 116, c81-c88.
DOI
|
47 |
Rossert, J. (2001) Drug-induced acute interstitial nephritis. Kidney Int. 60, 804-817.
DOI
ScienceOn
|
48 |
Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O., Weiler, T., Rush, D. and Nickerson, P. (2005) Proteomic-based identifi cation of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant. 5, 729-738.
DOI
|
49 |
Schetz, M., Dasta, J., Goldstein, S. and Golper, T. (2005) Drug-induced acute kidney injury. Curr. Opin. Crit. Care 11, 555-565.
DOI
|
50 |
Naughton, C. A. (2008) Drug-induced nephrotoxicity. Am. Fam. Physician. 78, 743-750.
|
51 |
Nerlich, A. G., Schleicher, E. D., Wiest, I., Specks, U. and Timpl, R. (1994) Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int. 45, 1648-1656.
DOI
|
52 |
Nielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M. and Kjeldsen, L. (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and infl ammatory bowel diseases. Gut 38, 414-420.
DOI
|
53 |
Nomura, S., Wills, A. J., Edwards, D. R., Heath, J. K. and Hogan, B. L. (1988) Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106, 441-450.
DOI
ScienceOn
|
54 |
Ohlsson, S., Wieslander, J. and Segelmark, M. (2003) Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin. Exp. Immunol. 131, 528-535.
DOI
|
55 |
Oldberg, A., Franzen, A. and Heinegard, D. (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. USA 83, 8819-8823.
DOI
ScienceOn
|
56 |
Olyaei, A. J., de Mattos, A. M. and Bennett, W. M. (1999) Immunosuppressant- induced nephropathy: pathophysiology, incidence and management. Drug Saf. 21, 471-488.
DOI
|
57 |
Palmer, B. F. (2002) Renal dysfunction complicating the treatment of hypertension. N. Engl. J. Med. 347, 1256-1261.
DOI
|
58 |
Patarca, R., Freeman, G. J., Singh, R. P., Wei, F. Y., Durfee, T., Blattner, F., Regnier, D. C., Kojak, C. A., Mock, B. A., Morse, H. C., Jerrells, T. R. and Cantor, H. (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene: Definition of a novel T cell dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 170, 145-161.
DOI
ScienceOn
|